Introduction
Disruption of the esophageal epithelial barrier and dysregulated cytokine responses are hallmarks of eosinophilic esophagitis (EoE), a chronic inflammatory disease characterized by dysphagia and food impaction [1-3]. G protein-coupled receptor 35 (GPR35) regulates macrophage cytokine responses and epithelial integrity [4, 5], yet its role in EoE remains undefined. While tryptophan metabolism and IL-18 have been associated with inflammation, how metabolic signals shape macrophage-epithelial crosstalk in EoE remains unclear [6-10]. We therefore sought to define this metabolite-driven pathway in EoE.
Aims & Methods
We investigated how GPR35 sensing of tryptophan-derived metabolites drives macrophage-epithelial signalling and epithelial barrier dysfunction in EoE, combining human metabolomics with genetic mouse models and ligand discovery approaches.
Results
Across independent datasets, GPR35 expression was elevated in active EoE versus controls or steroid-treated patients. Mice subjected to ovalbumin (OVA)-induced experimental EoE model exhibited higher levels of Gpr35 expression than the controls. Flow cytometry analysis of Gpr35-tdTomato reporter mice indicated predominant Gpr35 expression in macrophages and dendritic cells (DCs).
Single-cell RNA sequencing analysis of macrophage- and DC-derived cytokines in the murine esophagus during EoE revealed a shared profile including Il-18, Il-15, Il-16, Il-6, and TNF. However, only Il-18 was selectively reduced in Gpr35-deficient animals, a reduction that occurred in macrophages but not DCs as confirmed by flow cytometry. In addition, macrophages were the main producers of il-18 at steady state, compared with DCs. Consequently, macrophage-specific deletion of Gpr35 reduced esophageal inflammation in both sodium dodecyl sulfate- and OVA-driven EoE models, as demonstrated by decreased eosinophil infiltration and type 2 cytokine levels.
Molecular docking simulations identified 8-methoxykynurenate (8-MK) as a candidate endogenous GPR35 ligand, which inhibited forskolin-induced cAMP accumulation at a physiologically relevant concentration (IC₅₀ = 122.3 nM). Mass spectrometry revealed increased levels of 8-MK in active EoE patient biopsies. In human and murine macrophages, 8-MK induced IL-18 in a GPR35-dependent manner, and macrophage-specific deletion of Il-18 conferred similar protection, with reduced eosinophil numbers.
In contrast, 8-MK administration exacerbated disease, whereas pharmacological antagonism of GPR35 attenuated inflammation in murine EoE models. Mechanistically, 8-MK induced inflammasome activation and Il-18 maturation in macrophages, which was dependent on Gpr35-mediated Gi signaling and intracellular calcium flux, as indicated by pertussis toxin and calcium chelation experiments. In human esophageal organoids, IL-18 impaired epithelial barrier integrity, reducing transepithelial resistance and increasing macromolecule permeability.
Conclusion
We identify a myeloid-driven pathway linking tryptophan metabolism to EoE pathogenesis and epithelial barrier dysfunction. The tryptophan-derived metabolite 8-MK activates Gpr35 on macrophages to induce Il-18 via inflammasome signaling, while genetic ablation of Gpr35 or Il-18 confers protection across multiple EoE models. These data suggest a feed-forward loop in which 8-MK is sufficient to exacerbate disease and promotes macrophage-epithelial crosstalk, linking tryptophan metabolism, immunity, and barrier dysfunction in EoE.
References
- Biedermann L, Straumann A. Nat Rev Gastroenterol Hepatol. 2023;20(2):101–119.
- Furuta GT, Katzka DA. N Engl J Med. 2015;373(17):1640–1648.
- Underwood B, Troutman TD, Schwartz JT. Ann Allergy Asthma Immunol. 2023;130(1):28–39.
- Kaya B, et al. Cell Rep. 2020;32(5):107979.
- Melhem H, et al. Mucosal Immunol. 2022;15(3):443–458.
- Michaudel C, et al. Gut. 2023;72(7):1296–1307.
- Haq S, Grondin JA, Khan WI. FASEB J. 2021;35(10):e21888.
- Dutt P, et al. Immunol Cell Biol. 2015;93(10):849–857.
- Niranjan R, et al. Clin Immunol. 2015;157(2):103–113.
- Kandikattu HK, et al. Cytokine Growth Factor Rev. 2019;47:83–98.